Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lu AF35700 DDI Study
NCT03195946Phase 1Completed
- Sponsor
- Lundbeck
- Start
- Jun 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of lu af35700 in schizophrenia, sponsored by Lundbeck. Primary endpoints: Area under the plasma concentration-time curve from zero to infinity at Day 28 and Maximum observed concentration at Day 28. Started Jun 2017; status: completed.
02
Drugs
lu af35700
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT03195946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03195946.